4/A: Aehr Test Systems Director Amends Insider Sale Filing

Director Geoffrey G. Scott filed an amendment to a previous Form 4 to correct transaction prices and share quantities for spouse-held Aehr Test Systems stock.

Summary

• Director Geoffrey G. Scott filed an amendment to a Form 4 originally submitted on April 10, 2026.
• The amendment corrects errors regarding the sale of common stock held by his spouse on April 9, 2026.
• Adjustments include correcting the sale price of 25,000 shares to $68.12 and increasing the reported quantity of a separate transaction from 5,000 to 10,000 shares.
• The total beneficial ownership following these transactions was corrected to 100,000 shares held by the spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event; the filing is purely corrective and does not reflect a change in the company's operational or financial health.

Positives

• Transparency in correcting administrative reporting errors promptly.

Negatives

• Initial filing contained multiple inaccuracies regarding transaction prices and share volumes.

Risks

• Potential for regulatory scrutiny regarding the accuracy of Section 16 filings.

Future Outlook

No forward-looking guidance or strategic outlook provided in this administrative filing.

Industry Context

StockSavvy.ai notes that while administrative amendments to insider filings are common, they highlight the importance of rigorous internal controls over financial reporting and regulatory compliance for corporate insiders.

Comparison to Industry Standards

• The filing is a standard administrative correction consistent with SEC compliance requirements for public company directors.

Related Party Transactions

• Sale of 40,000 shares of common stock held by the spouse of Director Geoffrey G. Scott.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine administrative correction of insider transaction data.

Next Steps

• No further actions required beyond the filing of this amendment.

Key Dates

Keywords

Aehr Test Systems, AEHR, Insider Trading, Form 4, SEC Filing, Director Transaction